Bajaj Healthcare (BOM:539872) Notes Receivable: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539872 Bajaj Healthcare Ltd BOM:539872
62 GF Score
Price ₹328.35
GF Value ₹409.71
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Bajaj Healthcare Notes Receivable?

Bajaj Healthcare BOM:539872 +1.52% 62 Notes Receivable is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:539872 with a GF Score™ of 62/100 and a GF Value™ of ₹409.71 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Bajaj Healthcare's Notes Receivable for the quarter that ended in Jun. 2026 was ₹0 Mil.

Bajaj Healthcare Notes Receivable Related Terms

Bajaj Healthcare Notes Receivable Historical Data

* Premium members only.

The historical data trend for Bajaj Healthcare's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bajaj Healthcare Notes Receivable Chart

Bajaj Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bajaj Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:539872
62GF Score
Bajaj Healthcare Ltd BOM:539872
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bajaj Healthcare Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0 Mil mean?
Bajaj Healthcare (BOM:539872) has a Notes Receivable of ₹0 Mil as of Jun. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Bajaj Healthcare and its competitors.
Is Bajaj Healthcare's Notes Receivable too high?
Bajaj Healthcare's current Notes Receivable is ₹0 Mil. Overall, Bajaj Healthcare has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bajaj Healthcare's Notes Receivable compare to ZTS?
Bajaj Healthcare's Notes Receivable of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Bajaj Healthcare and its competitors. Bajaj Healthcare's current Notes Receivable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bajaj Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Bajaj Healthcare (BOM:539872) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹409.71, compared to a current price of ₹328.35 — trading 19.9% below its estimated fair value. The current Notes Receivable is ₹0 Mil. Bajaj Healthcare's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Bajaj Healthcare (BOM:539872), the current Notes Receivable is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bajaj Healthcare (BOM:539872) Overvalued in 2026?

Based on GuruFocus' analysis, Bajaj Healthcare stock appears to be undervalued. The current stock price of ₹328.35 is trading 19.9% below its estimated GF Value™ of ₹409.71. GuruFocus considers Bajaj Healthcare to be Modestly Undervalued.

Key valuation signals for BOM:539872:

  • Notes Receivable: ₹0 Mil
  • GF Value™: ₹409.71 vs. price of ₹328.35 (19.9% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the BOM:539872 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bajaj Healthcare Business Description

Other Exchanges BAJAJHCARE:India
Address Road No. 23, Wagle Industrial Estate, 602-606, Bhoomi Velocity Infotech Park, Plot No. B-39, B-39A, B-39A/1, Thane (West), Thane, MH, IND, 400 604
Bajaj Healthcare Ltd is an India-based pharmaceutical company that manufactures Active Pharmaceutical Ingredients (APIs), Intermediates, Finished Dosage Forms, and Nutraceuticals. Its products include Intermediates, API, Formulation, and Impurities. The company derives a majority of its revenue from India.
62GF Score

Get the complete analysis for BOM:539872

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹328.35
Price
₹409.71
GF Value